Nemera can help you with your licensing dossiers for ophthalmic molecules!

NEMERA NEWS

Looking for a license for a preservative-free multidose ophthalmic product?

Medical Device and OTC

Hyaluronic Sodium,
Hypromellose,
Carbomer…etc

Rx products

Bimatoprost,
Latanoprost,
Dorzolamide+Timolol…etc.

We can help you find the right ready-to-go dossier available for private labeling those molecules with Novelia®!

Thanks to its unique innovative design, Novelia® has been approved as packaging component and delivery system of multidose drug product formulated without preservatives.

Approved as packaging
of Medical Devices and OTC

in many markets globally

Approved as packaging
of Drug Products

in Europe, India and Latin America

1 DMF
for the USA FDA
covering the full system

User-friendly and intuitive, Novelia® contributes to improve patients’ life, allowing the delivery of safe unpreserved eye drops and improving the patients’ adherence to treatments.

Novelia® represents a major innovation in ophthalmic drug delivery by providing a preservative-free alternative for chronic treatments with the convenience of a bottle.

Novelia licensing

 


About Nemera
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Ophthalmic (multi-dose, preservative-free eyedroppers), Nasal, buccal, auricular (pumps, valves and actuators for sprays), Inhalation (pMDIs, DPIs),  Dermal and transdermal (airless & atmospheric dispensers), Parenteral (auto-injectors, pens, safety devices & implanters).
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer-owned device manufacturing.